Estimating the long-term clinical and societal outcomes of ofatumumab compared with teriflunomide and evaluating the impact of immediate vs delayed high efficacy therapy in treating patients with relapsing multiple sclerosis in Spain

被引：0
|
作者：
Vudumula, U. [1 ]
Patidar, M. [2 ]
Gudala, K. [2 ]
Karpf, E. [3 ]
Adlard, N. [4 ]
机构：
[1] Novartis Ireland Ltd, Dublin, Ireland
[2] Novartis Healthcare Pvt Ltd, Hyderabad, India
[3] Novartis Colombia SA, Bogota, Colombia
[4] Novartis Pharma AG, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P913
引用
收藏
页码：736 / 736
页数：1
相关论文
共 45 条
  • [1] Evaluating the impact of early vs delayed ofatumumab initiation and estimating the long-term outcomes of ofatumumab vs teriflunomide in relapsing multiple sclerosis patients in Spain
    Vudumula, Umakanth
    Patidar, Mausam
    Gudala, Kapil
    Karpf, Elizabeth
    Adlard, Nicholas
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 11 - 18
  • [2] EVALUATING THE LONG-TERM CLINICAL, SOCIETAL, AND ECONOMIC OUTCOMES OF OFATUMUMAB VS TERIFLUNOMIDE/INTERFERON ?-1A AND THE IMPACT OF EARLY VS DELAYED OFATUMUMAB INITIATION IN RELAPSING MULTIPLE SCLEROSIS PATIENTS IN GREECE
    Petropoulos, A.
    Vudumula, U.
    Patidar, M.
    Tiwari, S.
    Brennan, R.
    Kapsogeorgiou, K.
    Cheilas, G.
    Banhazi, J.
    VALUE IN HEALTH, 2022, 25 (12) : S119 - S120
  • [3] LONG-TERM EFFICACY OF OFATUMUMAB IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
    Hauser, Stephen
    Fox, Edward
    Aungst, Angela
    Su, Wendy
    Zielman, Ronald
    Das Gupta, Ayan
    Stoneman, Dee
    Robertson, Derrick
    Cohen, Jeffrey
    Kappos, Ludwig
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [4] Long-term safety and efficacy of teriflunomide in patients with relapsing forms of multiple sclerosis in the TEMSO extension trial
    Freedman, M.
    Wolinsky, J.
    Comi, G.
    Kappos, L.
    Olsson, T.
    Miller, A.
    Benamor, M.
    Dukovic, D.
    Liang, J.
    Truffinet, P.
    O'Connor, P.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 225 - 225
  • [5] Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study
    Miller, Aaron E.
    Olsson, Tomas P.
    Wolinsky, Jerry S.
    Comi, Giancarlo
    Kappos, Ludwig
    Hu, Xueqiang
    Xu, Xianhao
    Lublin, Alex L.
    Truffinet, Philippe
    Chavin, Jeffrey
    Delhay, Jean-Luc
    Benamor, Myriam
    Purvis, Annie
    Freedman, Mark S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [6] Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes
    Scott, Thomas E.
    Gettings, Edward J.
    Hackett, Christopher T.
    Schramke, Carol J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 5 : 1 - 6
  • [7] Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in Germany
    Koeditz, Dominik
    Frensch, Juergen
    Bierbaum, Martin
    Ness, Nils-Henning
    Ettle, Benjamin
    Vudumula, Umakanth
    Gudala, Kapil
    Adlard, Nicholas
    Tiwari, Santosh
    Ziemssen, Tjalf
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2022, 8 (01)
  • [8] Simulating Long-term Outcomes of Early vs Delayed Use of Highly Effective Disease Modifying Therapies in Relapsing Multiple Sclerosis
    Inojosa, Hernan
    Schriefer, Dirk
    Ness, Nils-Henning
    Dillenseger, Anja
    Akguen, Katja
    Ziemssen, Tjalf
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 836 - 836
  • [9] Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis Patients: Impact of Clinical and Demographic Factors on Disease Progression
    Barcutean, Laura
    Maier, Smaranda
    Bajko, Zoltan
    Stoian, Adina
    Mosora, Oana
    Sarmasan, Emanuela
    Manescu, Ion-Bogdan
    Balasa, Rodica
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)
  • [10] Safety and clinical efficacy outcomes from the Long-term extension study of tolebrutinib in patients with relapsing multiple sclerosis: 2-year results
    Oh, J.
    Syed, S.
    Orogun, L.
    Xu, Z.
    Turner, T. J.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 342 - 343
12345